explore -WSS

explore

author：hotspot 2025-10-01 00:46:53 - browse：3294

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Arc Institute generative AI designs new CRISPR systems

WSS

Military medical care influenced by rank and race, new study finds

CMS should re

FDA needs staff influx to meet gene therapy needs, Marks says

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Radiology is caught between AI's potential and concern for patients

Wikipedia

explore

hotspot

Virginia high school admissions case could be legal follow

It's time to retire 'poor historian' from clinicians' vocabularies

Heart attack and stroke risk calculators need revising

Anxious about a speech? A startup wants you to pop a minty cardiac drug

The high cost of giving birth even with insurance

CMS should re

In Memoriam: Notable people who died in 2023

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Novavax promises a turnaround & Lilly roils the obesity market

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

explore

It's time to retire 'poor historian' from clinicians' vocabularies

Patients' immediate access to test results puts radiologists in a bind

Pregnancy discrimination could be enabled by AI

Venture capitalist Bob Kocher on the state of digital health

NVIDIA and Google execs on the future of AI and drug discovery

Military medical care influenced by rank and race, new study finds

hotspot

hotspot

focus

hotspot